Johnson & Johnson (NYSE: JNJ) is launching the latest version of its intravascular lithotripsy catheter for cracking calcium within the coronary arteries, which the company said it designed to cut treatment times in half. The Shockwave C2 Aero … [Read More...] about J&J launches faster Shockwave coronary catheter in the US
Main Content
Medical Tubing & Extrusion
J&J launches faster Shockwave coronary catheter in the US
Johnson & Johnson (NYSE: JNJ) is launching the latest version of its intravascular lithotripsy catheter for cracking calcium within the coronary arteries, which the company said it designed to cut treatment times in half. The Shockwave C2 Aero … [Read More...] about J&J launches faster Shockwave coronary catheter in the US
Haemonetics wins FDA approval of PerQseal Elite vascular closure system
Haemonetics (NYSE: HAE) has received FDA approval for its PerQseal Elite vascular closure system for large-bore arterial procedures, following the company's $116.4 million acquisition of Vivasure Medical in January 2026. The FDA approval, … [Read More...] about Haemonetics wins FDA approval of PerQseal Elite vascular closure system
E2’s pulmonary embolism platform claims two FDA clearances
Endovascular Engineering (E2) has received a pair of FDA clearances for its pulmonary embolism treatment platform, spanning its dual-action thrombectomy system and hardware that returns filtered blood to the patient. The Hēlo system combines … [Read More...] about E2’s pulmonary embolism platform claims two FDA clearances
FDA approves Gore bridging stent graft in complex aortic aneurysms
W. L. Gore & Associates received expanded FDA approval, broadening the use of its balloon-expandable stent graft, opening it up for the treatment of complex aortic aneurysms. The Viabahn VBX endoprosthesis was greenlit for use in both … [Read More...] about FDA approves Gore bridging stent graft in complex aortic aneurysms
J&J delivers Shockwave data sustaining below-the-knee gains for two years
Johnson & Johnson MedTech (NYSE: JNJ) shared extended clinical findings from its Shockwave intravascular lithotripsy system, from a study aimed at clearing calcified vessel blockages below the knee in patients with peripheral artery … [Read More...] about J&J delivers Shockwave data sustaining below-the-knee gains for two years
Endologix is now Rhevera Medical
Endologix, maker of minimally invasive devices to treat vascular diseases, has rebranded as Rhevera Medical. In a news release posted yesterday, the Santa Rosa, California–based company said the name combines "rheo," Greek for flow, and "vera," … [Read More...] about Endologix is now Rhevera Medical
Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
Medtronic (NYSE:MDT) has secured a breakthrough designation from the FDA for a version of its drug-coated balloon aimed at unblocking arteries below the knee, following years of development. The In.Pact BTK catheter is slated for an international, … [Read More...] about Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
